AdvanCell
AdvanCell, Inc.
AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
advancell.com.au · Cambridge, MA
Funding event
The round itself, as filedInferred stageSeries C+
Sold of offered$218M of $315M
Filed2026-07-16
Days since filing80
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-06-30
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Philina LeeExecutive Officer · Director
- Aaron PickettExecutive Officer
- Wing Cheong LamDirector
- Nik EconomopoulosDirector
- Anthony AiudiDirector
- Bali MuralidharDirector
- Jamil BegDirector
- Christopher GagliardiDirector
- Andrew AdamovichDirector
- Andrew KayDirector
- Kevin CameronDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged69.3% sold3.1 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-2310
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Director of FacilitiesSEP 23Richlands, Brisbane, QLD, AU · Technical Operations · Full-time · open 11 days
- Director of Radiochemical SeparationsSEP 23Richlands, Brisbane, QLD, AU · Isotope Development · Full-time · open 11 days
- Director, Clinical-Translational ScienceSEP 23Brisbane, QLD, Australia · Clinical · Full-time · open 11 days
- US Site Quality LeadSEP 23Andover, MA · Technical Operations · Full-time · open 11 days
- Director, CMC – Precursor Development & ManufacturingSEP 23Boston, MA · Technical Operations · Full-time · open 11 days
- Director, CMC – Radiopharmaceutical Process DevelopmentSEP 23Boston, MA · Technical Operations · Full-time · open 11 days
- Senior Radiochemist, R&D Technical Development (Pb212 isotope)SEP 23Richlands, Brisbane, QLD, AU · Isotope Development · Full-time · open 11 days
- US Director, Health Safety & Environment (HSE)SEP 23Andover, MA · Technical Operations · Full-time · open 11 days
- Associate Director, CMC – Analytical DevelopmentSEP 23Boston, MA · Technical Operations · Full-time · open 11 days
- Associate Director, Trial Operations & BudgetSEP 23Boston, MA · Clinical · Full-time · open 11 days
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.